Sign up to save your podcasts
Or
Share Eyewire News: The Podcast
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Eyewire News: The Podcast
Eyewire News: The Podcast episodes
- Breaking News From the AAO Annual Meeting in New Orleans (Part 2 of 2)
Eyewire News the Podcast reports on new products and breaking news live from thee American Academy of Ophthalmology meeting in New Orleans.
Learn more about your ad choices. Visit megaphone.fm/adchoices
13 min - Breaking News From the AAO Annual Meeting in New Orleans (Part 1 of 2)
Eyewire News the Podcast reports on new products and breaking news live from thee American Academy of Ophthalmology meeting in New Orleans.
Learn more about your ad choices. Visit megaphone.fm/adchoices
11 min - Special Report: Potential of Robotic Cataract Surgery
Leaders pioneering fully robotic assisted cataract surgery, discussed the technology and shared their experience treating the first human patients.
Learn more about your ad choices. Visit megaphone.fm/adchoices
10 min - Kodiak Plans to Submit BLA for Zenkuda After Phase 3 Data
Kodiak Sciences meets its primary endpoint in a phase 3 trial for its DME drug candidate clearing the way for a regulatory submission; the European Commission approves Roche’s Susvimo for wet AMD; and Merck announces topline results from a pivotal phase 2b/3 trial evaluating two doses of its DME treatment candidate.
Learn more about your ad choices. Visit megaphone.fm/adchoices
7 min - Breaking News From the ESCRS Congress in London (Part 2 of 2)
EyewireTV reports on new products and breaking news live from the ESCRS Congress in London.
Learn more about your ad choices. Visit megaphone.fm/adchoices
9 min - Breaking News From the ESCRS Congress in London (Part 1 of 2)
EyewireTV reports on new products and breaking news live from the ESCRS Congress in London.
Learn more about your ad choices. Visit megaphone.fm/adchoices
11 min - FDA Accepts Nanoscopes's Optogenetic Gene Therapy BLA
The FDA accepts a biologics license application (BLA) for a first-of-its-kind optogenetic gene therapy for RP; a software upgrade from Heru combines several pretesting assessments into a single guided workflow; and a new FDA-approved overnight orthokeratology lens is launched in the US.
Learn more about your ad choices. Visit megaphone.fm/adchoices
5 min - FDA Sets PDUFA Date for Investigational Glaucoma Eye Drop
The FDA accepts Nicox’s NDA for an investigational glaucoma drop; Bausch + Lomb provides updates on two key investigational therapies for dry eye and ocular surface pain; and Ocugen doses the first patient in a global phase 3 trial of an investigational gene therapy for geographic atrophy (GA).
Learn more about your ad choices. Visit megaphone.fm/adchoices
7 min - EyePoint Misses Primary Endpoint in Phase 3 Trial But Sees Promise After Analysis
Eyepoint Pharmaceuticals releases key phase 3 data for its wet AMD drug Duravyu; Zeiss receives FDA clearance for a cloud- and browser-based data management solution; and the FDA expands Sight Sciences’ indications for the TearCare System for the treatment of MGD.
Learn more about your ad choices. Visit megaphone.fm/adchoices
6 min - Three Major Acquisitions Announced in Ophthalmology
Tarsus Pharmaceuticals enters into a definitive agreement to acquire Alkeus Pharmaceuticals; Harrow acquires dry eye disease nasal spray Tyrvaya from Viatris; and Italy-based Alfasigma enters into a share purchase agreement with Sever Life Sciences to acquire 100% of Nordic Pharma and its subsidiaries.
Learn more about your ad choices. Visit megaphone.fm/adchoices
6 min
About Eyewire News: The Podcast
From the publisher's feed
Eyewire News: The Podcast keeps listeners updated with the latest information in the ophthalmic field, featuring breaking news from press releases, medical journals, vision publications, and…
other news sources.